InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Fry Hannah. Officer active across 1 company, notably Protara Therapeutics, Inc.. In total, 12 disclosures have been published. Activity tracked since 16 July 2022. The latest transaction was disclosed on 26 January 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Fry Hannah is a declarant linked to Protara Therapeutics, Inc., where the listed role is VP, Controller. She has 12 filings in total, and within the recent sampled filings held, the date range runs from 2022-07-19 to 2026-01-27, with the dominant transaction nature listed as tax withholding.